Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Yiyi Yu"'
Autor:
Qing Liu, Mengling Liu, Zhiguo Zou, Jinyi Lin, Ningping Zhang, Lin Zhao, Jiahua Zhou, Haojie Zhou, Xin Zhou, Xiaodong Jiao, Yiyi Yu, Tianshu Liu
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Treatment strategy against immune-related adverse events (irAEs) induced by immune checkpoint inhibitors (ICIs) frequently requires other immunosuppressive agents. Tofacitinib is a rapidly acting JAK-STAT inhibitor with proven eff
Externí odkaz:
https://doaj.org/article/0e8938951843488299fc84183f272dff
Autor:
Xiaojing Xu, Luoyan Ai, Keshu Hu, Li Liang, Minzhi Lv, Yan Wang, Yuehong Cui, Wei Li, Qian Li, Shan Yu, Yi Feng, Qing Liu, Ying Yang, Jiao Zhang, Fei Xu, Yiyi Yu, Tianshu Liu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Immunotherapy confers little to no benefit in the treatment of microsatellite stable (MSS) metastatic colorectal cancer (mCRC). Mechanistic insights suggested that epidermal growth factor receptor (EGFR) antibody plus irinotecan might augmen
Externí odkaz:
https://doaj.org/article/c52ef4cf4de347268916103efecfb9a4
Autor:
Jiayu Zhang, Yu Dong, Shan Yu, Keshu Hu, Lingyun Zhang, Min Xiong, Mengling Liu, Xun Sun, Suyao Li, Yitao Yuan, Chi Zhang, Mengxuan Zhu, Yichou Wei, Yanjing Zhu, Yiyi Yu, Pengfei Zhang, Tianshu Liu
Publikováno v:
Cell Death and Disease, Vol 15, Iss 7, Pp 1-15 (2024)
Abstract In recent years, immunotherapy, particularly PD-1 antibodies, have significantly enhanced the outcome of gastric cancer patients. Despite these advances, some patients do not respond well to treatment, highlighting the need to understand res
Externí odkaz:
https://doaj.org/article/e36a9c12b7294c108f7913e3bfca937c
Autor:
Yiyi Yu, Zhening Zhang, Mengxuan Zhu, Yu Shan, Yan Wang, Li Wei, Xuan Huang, Debin Sun, Zhao Peng, Tianshu Liu
Publikováno v:
Clinical and Translational Discovery, Vol 4, Iss 4, Pp n/a-n/a (2024)
Abstract Background Despite advances in treatments for gastric cancer (GC), new targets are needed to enhance treatment, especially when mesenchymal‐epithelial transition (MET) amplification is involved. Therefore, we investigated the genomic featu
Externí odkaz:
https://doaj.org/article/4d4e0183926441c6b7abf10b8865a1e1
Autor:
Yizhi Xiao, Lezhao Zhu, Renhao Liang, Jiequan Su, Junqi Yang, Xinyi Cao, Yao Lu, Yiyi Yu, Junjie Hu
Publikováno v:
Comparative Immunology Reports, Vol 7, Iss , Pp 200162- (2024)
Black soldier fly (BSF) meal possesses a balanced nutritional profile, making it a promising substitute for fishmeal. Several studies have been conducted to investigate the effects of replacing fishmeal with BSF meal on fish immune response and antio
Externí odkaz:
https://doaj.org/article/e341152fefc94948a421c6b7b327f0a3
Publikováno v:
Cancer Medicine, Vol 12, Iss 19, Pp 19583-19594 (2023)
Abstract Background The clinicopathological features of MET‐amplified gastric cancer (GC) and real‐world data on the efficacy of MET‐targeted therapies remain unknown. Pulmonary lymphangitis carcinomatosis (PLC) is a peculiar manifestation of G
Externí odkaz:
https://doaj.org/article/f9989ea2b0604b71ac7fc9f6584f7573
Autor:
Yuehong Cui, Yiyi Yu, Song Zheng, Jie’er Ying, Yi’an Du, Yan Wang, Xuefei Wang, Zhenbin Shen, Fenglin Liu, Minzhi Lv, Yihong Sun, Tianshu Liu
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background The Neo-REGATTA study evaluated the effectiveness and safety of Docetaxel, oxaliplatin, and S-1 (DOS regimen) followed by radical resection vs. chemotherapy in advanced gastric adenocarcinoma patients with single non-curable facto
Externí odkaz:
https://doaj.org/article/20b8cb8643054d398233d66b42c47066
Publikováno v:
Cancer Medicine, Vol 12, Iss 2, Pp 1114-1121 (2023)
Abstract Purpose The prognosis of diffuse‐type gastric cancer (DGC) is poorer than that of intestinal type, but S‐1 is a potential treatment option in DGC. This study explored the maximal tolerated dose (MTD) and the recommended dose for phase II
Externí odkaz:
https://doaj.org/article/8136f028294647a49d4384a62c11a48f
Autor:
Zhaoqing Tang, Yan Wang, Dan Liu, Xuefei Wang, Chen Xu, Yiyi Yu, Yuehong Cui, Cheng Tang, Qian Li, Jing Sun, Qian Zhang, Yuan Ji, Guifen Ma, Haojie Li, Zhenbin Shen, Kuntang Shen, Rongrong Zheng, Zhiguo Hou, Tianshu Liu, Jiping Wang, Yihong Sun
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
Surgery is an important part of treatment for gastric adenocarcinoma, however, the consensus on perioperative care is less clear. Here, the authors report the results of a phase II clinical trial investigating neoadjuvant camrelizumab with concurrent
Externí odkaz:
https://doaj.org/article/f6b144877d964639a92b197bb418dedf
Autor:
Mengxuan Zhu, Erbao Chen, Shan Yu, Chen Xu, Yiyi Yu, Xin Cao, Wei Li, Pengfei Zhang, Yan Wang, Baofeng Lian, Shuirong Zhang, Yueting Qu, Lujia Huang, Weiwei Shi, Yuehong Cui, Li Qian, Tianshu Liu
Publikováno v:
Cancer Communications, Vol 42, Iss 10, Pp 1032-1035 (2022)
Externí odkaz:
https://doaj.org/article/55f6bdecef79400b8d7d9d59896349ec